Prostaglandin inhibition and cardiovascular risk: Maybe timing really is everything Journal Article
| Authors: | Bertagnolli, M. M.; Zauber, A. G.; Solomon, S. |
| Article Title: | Prostaglandin inhibition and cardiovascular risk: Maybe timing really is everything |
| Keywords: | treatment outcome; case control study; drug tolerability; review; cancer risk; drug efficacy; drug safety; gastrointestinal hemorrhage; treatment duration; clinical trials as topic; drug megadose; neoplasm; neoplasms; colorectal cancer; animals; cancer prevention; opiate; prevalence; drug effect; risk; carcinogenesis; acetylsalicylic acid; celecoxib; paracetamol; cyclooxygenase 2 inhibitor; cardiovascular disease; cardiovascular risk; colorectal adenoma; heart death; cardiovascular diseases; cyclooxygenase 2 inhibitors; cyclooxygenase 2; diclofenac; eflornithine; etoricoxib; ibuprofen; indometacin; naproxen; nonsteroid antiinflammatory agent; prostaglandin; prostanoid receptor; proton pump inhibitor; rofecoxib; salsalate; sulindac; tramadol; acute heart infarction; arthritis; atherosclerosis; cardiotoxicity; chronic arthritis; stomach ulcer; thrombosis; anti-inflammatory agents, non-steroidal; anticarcinogenic agents; cardiovascular system; prostaglandin antagonists; prostaglandins |
| Journal Title: | Cancer Prevention Research |
| Volume: | 2 |
| Issue: | 3 |
| ISSN: | 1940-6207 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2009-03-01 |
| Start Page: | 195 |
| End Page: | 196 |
| Language: | English |
| DOI: | 10.1158/1940-6207.capr-08-0245 |
| PUBMED: | 19258547 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "Source: Scopus" |
